Zenas BioPharma

IPO

Enabling patients with autoimmune diseases to reimagine life.

Public · Boston, United States · Founded 2022 · $318.0M raised

Employees
51–200
Founded
2022
Business Model
B2B
Total Funding
$318.0M
Last Round
$200.0M Series CMay 2024
Rounds
2
Type
Public

About

Zenas BioPharma is a clinical-stage global biopharmaceutical company focused on developing and commercializing transformative immunology-based therapies for autoimmune diseases with significant unmet patient needs. The company's proven leadership team advances a pipeline targeting conditions where current treatments remain inadequate. Zenas operates with a global development model, combining scientific rigor with commercial strategy.

Summary

Zenas BioPharma is a Biotech company based in Boston, United States, founded in 2022. It has raised $318.0M in total across 2 rounds, most recently a $200.0M Series C round in May 2024. Investors include SR One, Khosla Ventures and NEA.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

IPOSep 2024
$225.0M

Sign up to see all 3 rounds

Series B through IPO — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Zenas BioPharma on Indexed.vc
<a href="https://indexed.vc/companies/zenas-biopharma"><img src="https://indexed.vc/api/badge/company/zenas-biopharma" alt="Zenas BioPharma on Indexed.vc" width="260" height="76" /></a>